DOCSLIB.ORG

PROGRAM BOOK EXECUTIVE COMMI EE Urological Society, Inc

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PROGRAM BOOK EXECUTIVE COMMI EE Urological Society, Inc 2013 Annual Meeting March 8 – 10, 2013 Urological Society, Inc. Great Wolf Lodge Wisconsin Dells, Wisconsin HOWARD B. GOLDMAN, MD, FACS Center for Quality and Patient Safety | Glickman Urologic and Kidney Institute The Cleveland Clinic | Cleveland, OH GLENN M. PREMINGER, MD Chief, Division of Urologic Surgery Duke University Medical Center | Durham, NC GRANVILLE LLOYD, MD University of Wisconsin | Madison, WI STEPHEN Y. NAKADA, MD Chairman, Dept. of Urology University of Wisconsin | Madison, WI FEATURED SPEAKERS FEATURED MICHAEL GURALNICK, MD Medical College of Wisconsin | Milwaukee, WI PROGRAM BOOK EXECUTIVE COMMIEE Urological Society, Inc. Wisconsin Urological Society Executive Committee President David R. Paolone, MD Madison, WI President-Elect Jay I. Sandlow, MD Milwaukee, WI Secretary/Treasurer John V. Kryger, MD Milwaukee, WI Immediate Past President James A. Wright, MD Fond du Lac, WI Wisconsin Representative to NCS Board of Directors John V. Kryger, MD Milwaukee, WI 2013 Program Planning Committee David R. Paolone, MD John V. Kryger, MD Executive Director Wendy J. Weiser Managing Director Sue O’Sullivan Associate Director Mary Tully Message from the President Dear WUS Members, As president of the Wisconsin Urological Society, it is my privilege to welcome you to the annual meeting in the Wisconsin Dells, March 8 – 10, 2013. The two-day academic format has worked well the past two years, and we are continuing it for the 2013 meeting to maximize the amount of educational content provided by the meeting. Our guest speakers for the meeting are Dr. Howard Goldman from the Cleveland Clinic Foundation and Dr. Glenn Preminger of Duke University. Dr. Goldman is a specialist in female urology and will be lecturing on management of overactive bladder and surgical treatment of stress urinary incontinence. Dr. Preminger is a renowned expert on the surgical and medical management of stone disease. In addition, the academic program includes presentations from the faculty and residents of the University of Wisconsin, Madison and Medical College of Wisconsin programs. The annual meeting is at the Great Wolf Lodge in the Wisconsin Dells, and I encourage members to bring their families to the meeting to enjoy a fun-filled weekend in the “Waterpark Capital of the World.” The Welcome Reception for members on Friday night allows for reconnecting with friends and colleagues from around the state, and a casual interaction with our industry sponsors. The Annual Banquet is on Saturday night, and it allows members to be able to show off their bowling skills afterwards. This promises to be another great meeting academically and socially, and I look forward to seeing you. David R. Paolone, MD President, WUS 1 About the Program Wisconsin Urological Society Residents Program The Wisconsin Urological Society recognizes the need for urology residents to network with, and be mentored by, experienced urologists in the field. To enhance their training, the WUS features presentations by residents enrolled in a Wisconsin Teaching Institution’s urology resident program. The WUS’ yearly resident podium presentations will take place on Saturday and Sunday, March 9 – March 10, during the society’s annual meeting. All urology residents in the state of Wisconsin are encouraged to submit abstracts for presentation. Topics may be clinical or basic science and cover any area in urology. All accepted abstracts are presented to the society during the general session on Saturday and Sunday. Awards will be given to best resident podium presentations from both Milwaukee and Madison. This meeting is a great opportunity to share residency training and research ideas, as well as network with urologists in the state. Disclaimer Statement Statements, opinions and results of studies contained in the program and abstracts are those of the presenters/authors and do not reflect the policy or position of the WUS nor does the WUS provide any warranty as to their accuracy or reliability. Every effort has been made to faithfully reproduce the abstracts as submitted. However, no responsibility is assumed by the WUS for any injury and/or damage to persons or property from any cause including negligence or otherwise, or from any use or operation of any methods, products, instruments, or ideas contained in the material herein. Copyright Notice Individuals may print out single copies of abstracts or slides contained in this publication for personal, non-commercial use without obtaining permission from the author or the WUS. Permission from both the WUS and the author must be obtained when making multiple copies for personal or educational use, for reproduction, for advertising or promotional purposes, for creating new collective works, for resale or for all other uses. Filming/Photography Statement No attendee/visitor at the WUS 2013 annual meeting may record, film, tape, photograph, interview, or use any other such media during any presentation, display, or exhibit without the express, advance approval of the WUS Executive Director. This policy applies to all WUS members, non-members, guests, and exhibitors, as well as members of the print, online, or broadcast media. 2 Needs & Objectives Educational Needs Urologists require continuing educational enrichment to keep abreast of the developments in the field. Urology is rapidly changing and new medications, chemotherapy, surgical techniques and technology have a great impact on patient care, as well as healthcare economics. Urologists must assimilate this knowledge and make medical decisions for the best intentions of the patient. Often this translation of knowledge is facilitated by academic centers to community urologists. Specifically, urologists must be aware of emerging trends in pediatric urology, robotic surgery, prostate cancer, sexual medicine and infertility, voiding dysfunction and BPH, renal cancer and healthcare socioeconomics. Educational Objectives At the conclusion of the WUS 2013 meeting, attendees should be able to: 1. Describe the basic pathophysiology of nephrolithiasis. 2. Explain the indications and options for the medical evaluation of recurrent and first time stone formers. 3. Identify an effective algorithm for the medical management of nephrolithiasis. 4. Explain the indications and options for the management of renal and ureteral calculi. 5. Describe the surgical techniques for ureteroscopic management of ureteral calculi. 6. Identify an effective algorithm for the management of complex renal calculi. 7. Review mechanism of action of botulinum toxin in neurogenic bladder. 8. Review indications for use of botulinum toxin in neurogenic bladder. 9. Review efficacy of botulinum toxin in neurogenic bladder. 10. Review and discuss new techniques and indications for robotically assisted surgery in high risk prostate cancer and cystectomy. 11. Review and discuss new techniques and indications for robotically assisted surgery in patients who have had prior surgery. 12. Explain new techniques in robotically assisted reconstructive surgery. 13. Review and discuss new techniques in robotically assisted microsurgery. 14. Analyze data pertaining to various pharmacologic and surgical treatments for voiding dysfunction and urinary incontinence. 15. Evaluate and make informed choices regarding diagnostic work-up, testing, and implementation of appropriate treatment strategies for overactive bladder and stress urinary incontinence. 16. Assess and manage complicated female incontinence. 17. Describe latest evidence-based data and state-of-the art care related to stress incontinence, pelvic prolapse and pelvic reconstructive surgery. 18. Identify recent legislative bills in Wisconsin impacting urology. 19. Identify mechanisms that can be utilized by urologist to advocate for political action. 3 Accreditation Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American College of Legal Medicine and the Wisconsin Urological Society. The American College of Legal Medicine is accredited by the ACCME to provide continuing medical education for physicians. The American College of Legal Medicine designates this live activity for a maximum of 9.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Conflict Resolution Statement The American College of Legal Medicine CME Office has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable. General Disclaimer The statements and opinions contained in this program are solely those of the individual authors and contributors and not of the Wisconsin Urological Society. The appearance of the advertisements is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. The content of this publication may contain discussion of off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses. The Wisconsin Urological Society disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the abstracts or advertisements. Special Assistance We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us better serve you. Call (847) 517-7225
Load more

Recommended publications
  • The History of Microsurgery in Urological Practice
    Chen-1 The History of Microsurgery in Urological Practice Mang L. Chen1, Gregory M. Buncke2 and Paul J. Turek3 1G.U. Recon, San Francisco, CA, 94114 2The Buncke Clinic, San Francisco, CA 94114 3The Turek Clinic, Beverly Hills, CA 90210 Correspondence to: Mang Chen, MD G.U. Recon 45 Castro St, Suite 111 San Francisco, CA 94114 Tel: 415-481-3980 Email: [email protected] Chen-2 Abstract Operative microscopy spans all surgical disciplines, allowing human dexterity to perform beyond direct visual limitations. Microsurgery started in otolaryngology, became popular in reconstructive microsurgery, and was then adopted in urology. Starting with reproductive tract reconstruction of the vas and epididymis, microsurgery in urology now extends to varicocele repair, sperm retrieval, penile transplantation and free flap phalloplasty. By examining the peer reviewed and lay literature this review discusses the history of microsurgery and its subsequent development as a subspecialty in urology. Keywords: urology, microsurgery, phalloplasty, vasovasostomy, varicocelectomy Chen-3 I. Introduction Microsurgery has been instrumental to surgical advances in many medical fields. Otolaryngology, ophthalmology, gynecology, hand and plastic surgery have all embraced the operating microscope to minimize surgical trauma and scar and to increase patency rates of vessels, nerves and tubes. Urologic adoption of microsurgery began with vasectomy reversals, testis transplants, varicocelectomies and sperm retrieval and has now progressed to free flap phalloplasties and penile transplantation. In this review, we describe the origins of microsurgery, highlight the careers of prominent microsurgeons, and discuss current use applications in urology. II. Birth of Microsurgery 1) Technology The birth of microsurgery followed from an interesting marriage of technology and clinical need.
    [Show full text]
  • Examining Male Infertility
    C O Examining Male Infertility N T I N U Susanne Quallich I N G n increasing number of Problems of male infertility can seem like minor issues within the couples seek evaluation larger realm of urology. But many male infertility diagnoses can be and treatment for infer- successfully treated, allowing the couple to conceive naturally or E tility, especially as more with minimal medical assistance. Some patients presenting with male D Acouples delay childbearing in infertility can have more significant disease. Treatments for male U order to establish their careers. A infertility will continue to progress, and as an increasing number of male factor alone is the cause of couples seek infertility services, the need to provide basic informa- C infertility in up to 20% of infer- tion grows as well. A tile couples and a contributing factor in another 30% to 40% of T all couples presenting for infertil- reproductive technologies. influence on overall male develop- I ity evaluations (American It is common to recommend ment and growth. Spermatogenesis O Urological Association [AUA] & an infertility evaluation in couples is driven by testosterone production N American Society for Reproduc- with a history of unprotected in the Leydig cells of the testes. tive Medicine (ASRM), 2001a; intercourse for at least 12 months Under the influence of luteinizing ASRM, 2004). Problems with without a pregnancy and with hormone (LH) and follicle-stimulat- infertility affect approximately 6.1 attempts to time intercourse with ing hormone (FSH), which are million people in the United ovulation, although this length of released from the anterior pituitary, States, or roughly 10% of the time can be shortened as the the testes begin to produce sperm in reproductive-age population.
    [Show full text]
  • Robotic Surgery for Male Infertility
    Robotic Surgery for Male Infertility Annie Darves-Bornoz, MD, Evan Panken, BS, Robert E. Brannigan, MD, Joshua A. Halpern, MD, MS* KEYWORDS Robotic surgical procedures Infertility Male Vasovasostomy Varicocele KEY POINTS Robotic-assisted approaches to male infertility microsurgery have potential practical benefits including reduction of tremor, 3-dimensional visualization, and decreased need for skilled surgical assistance. Several small, retrospective studies have described robotic-assisted vasectomy reversal with com- parable clinical outcomes to the traditional microsurgical approach. Few studies have described application of the robot to varicocelectomy, testicular sperm extrac- tion, and spermatic cord denervation. The use of robotic-assistance for male infertility procedures is evolving, and adoption has been limited. Rigorous studies are needed to evaluate outcomes and cost-effectiveness. INTRODUCTION with intraperitoneal and pelvic surgery. On the other hand, many of the theoretic and practical ad- Up to 15% of couples have infertility, with approx- 1,2 vantages offered by the robotic approach are imately 50% of cases involving a male factor. A highly transferrable to surgery for male infertility: substantial proportion of men with subfertility have surgically treatable and even reversible etiologies, High quality, 3-dimensional visualization is such as a varicocele or vasal obstruction. The essential for any microsurgical procedure. introduction of the operating microscope revolu- Improved surgeon ergonomics are always desir- tionized the field of male infertility, dramatically able, particularly given the surgeon morbidity improving visualization of small, complex associated with microsurgery.3 anatomic structures. The technical precision Filtering of physiologic tremor can improve pre- afforded has improved operative outcomes across cision during technically demanding micro- the board.
    [Show full text]
  • Urology Supplemental Guide
    Supplemental Guide for Urology Supplemental Guide: Urology April 2020 1 Supplemental Guide for Urology TABLE OF CONTENTS Introduction .................................................................................................................................... 3 Patient Care .................................................................................................................................... 4 Patient Evaluation ........................................................................................................................ 4 Peri-Procedural Care .................................................................................................................... 6 Endoscopic Procedures ............................................................................................................... 8 Open Procedures ......................................................................................................................... 9 Minimally Invasive Procedures (Laparoscopic and Robotic) ..................................................... 10 Office-Based Procedures ........................................................................................................... 12 Medical Knowledge ...................................................................................................................... 14 Clinical Medical Knowledge........................................................................................................ 14 Clinical Reasoning .....................................................................................................................
    [Show full text]
  • The Acute Scrotum 12 Module 2
    Department of Urology Medical Student Handbook INDEX Introduction 1 Contact Information 3 Chairman’s Welcome 4 What is Urology? 5 Urology Rotation Overview 8 Online Teaching Videos 10 Required Readings 11 Module 1. The Acute Scrotum 12 Module 2. Adult Urinary Tract Infections (UTI) 22 Module 3. Benign Prostatic Hyperplasia (BPH) 38 Module 4. Erectile Dysfunction (ED) 47 Module 5. Hematuria 56 Module 6. Kidney Stones 64 Module 7. Pediatric Urinary Tract Infections (UTI) 77 Module 8. Prostate Cancer: Screening and Management 88 Module 9. Urinary Incontinence 95 Module 10. Male Infertility 110 Urologic Abbreviations 118 Suggested Readings 119 Evaluation Process 121 Mistreatment/Harassment Policy 122 Research Opportunities 123 INTRODUCTION Hello, and welcome to Urology! You have chosen a great selective during your Surgical and Procedural Care rotation. Most of the students who take this subspecialty course enjoy themselves and learn more than they thought they would when they signed up for it. During your rotation you will meet a group of urologists who are excited about their medical specialty and feel privileged to work in it. Urology is a rapidly evolving technological specialty that requires surgical and diagnostic skills. Watch the video “Why Urology?” for a brief introduction to the field from the American Urological Association (AUA). https://youtu.be/kyvDMz9MEFA Urology at UW Urology is a specialty that treats patients with many different kinds of problems. At the UW you will see: patients with kidney problems including kidney cancer
    [Show full text]
  • Efficacy of Vasectomy Reversal According to Patency for The
    International Journal of Impotence Research (2012) 24, 202 -- 205 & 2012 Macmillan Publishers Limited All rights reserved 0955-9930/12 www.nature.com/ijir ORIGINAL ARTICLE Efficacy of vasectomy reversal according to patency for the surgical treatment of postvasectomy pain syndrome JY Lee1, JS Chang1, SH Lee1, WS Ham1, HJ Cho2,TKYoo2, KS Lee3, TH Kim3, HS Moon4, HY Choi4 and SW Lee4 This study was conducted to assess outcomes (according to patency) of vasectomy reversal (VR) in qualified patients with postvasectomy pain syndrome (PVPS). A total of 32 patients with PVPS undergoing VR between January 2000 and May 2010 were examined retrospectively. Of these, 68.8% (22/32) completed a study questionnaire, either onsite at the outpatient clinic or via telephone interview. Preoperative clinical findings, preoperative and postoperative visual analogue scale (VAS) pain scores, patency and pregnancy rate and overall patient satisfaction were analyzed. For the latter, a four-point rating of (1) cure, (2) improvement, (3) no change or (4) recurrence was used. The mean age was 45.09±4.42 years and the mean period of follow-up was 3.22 years (0.74--7.41). Patency rates were 68.2% (15/22) and pregnancy rates were 36.4% (8/22). The mean VAS was 6.64±1.00 preoperatively and 1.14±0.71 postoperatively (Po0.001). The difference in the mean preoperative and postoperative VAS was 6.00±1.25 (4--8) in the patency group and 4.43±0.98 (3--6) in the no patency group (P ¼ 0.011). A significant difference in procedural satisfaction with surgical outcome was observed between patency and no patency groups (P ¼ 0.014).
    [Show full text]
  • Robotic Surgery: Disruptive Innovation Or Unfulfilled Promise? a Systematic
    Surg Endosc and Other Interventional Techniques DOI 10.1007/s00464-016-4752-x Robotic surgery: disruptive innovation or unfulfilled promise? A systematic review and meta-analysis of the first 30 years 1 1 1 1 Alan Tan • Hutan Ashrafian • Alasdair J. Scott • Sam E. Mason • 1 1 1,2 Leanne Harling • Thanos Athanasiou • Ara Darzi Received: 25 August 2015 / Accepted: 11 January 2016 Ó The Author(s) 2016. This article is published with open access at Springerlink.com Abstract (RoM 0.982, 0.936–1.027) and 30-day overall complication Background Robotic surgery has been in existence for rate (RR 0.988, 0.822–1.188). In both comparisons, robotic 30 years. This study aimed to evaluate the overall periop- surgery prolonged operative time (OS: RoM 1.073, erative outcomes of robotic surgery compared with open 1.022–1.124; MIS: RoM 1.135, 1.096–1.173). The benefits of surgery (OS) and conventional minimally invasive surgery robotic surgery lacked robustness on RCT-sensitivity analy- (MIS) across various surgical procedures. ses. However, many studies, including the relatively few Methods MEDLINE, EMBASE, PsycINFO, and Clini- available RCTs, suffered from high risk of bias and inadequate calTrials.gov were searched from 1990 up to October 2013 statistical power. with no language restriction. Relevant review articles were Conclusions Our results showed that robotic surgery hand-searched for remaining studies. Randomised con- contributed positively to some perioperative outcomes but trolled trials (RCTs) and prospective comparative studies longer operative times remained a shortcoming. Better (PROs) on perioperative outcomes, regardless of patient quality evidence is needed to guide surgical decision age and sex, were included.
    [Show full text]
  • Male Genital Surgical Procedures
    MALE GENITAL SURGICAL PROCEDURES Male Genital Surgical ProceduresApril 1, 2015 PENIS Asst Surg Anae INCISION Slit of prepuce (complete care) # S567 - newborn ............................................................................................................. 14.35 # S568 - infant .................................................................................................................. 21.50 6 # S569 - adult or child....................................................................................................... 30.256 EXCISION Circumcision - for physical symptomatology only # S573 - for patients aged one year or older .................................................................... 6 179.40 6 # S577 - for infants less than one year of age.................................................................. 6 90.05 6 Note: 1. Circumcision is an insured service only when medically necessary. As such, circumcision performed for ritual, cultural, religious or cosmetic reasons at any age is not an insured service. 2. Circumcision for neonatal phimosis is not an insured service. Z702 Biopsy ...................................................................................................................... 23.55 6 E542 - when performed outside of hospital..........................................................add 11.15 Amputation # S574 - partial ................................................................................................................. 6 170.65 7 # S575 - partial with inguinal glands 1 or 2
    [Show full text]
  • Advancing Men's Reproductive Health in the US: Current
    ADVANCING MEN’S REPRODUC TIVE HEALTH IN THE UNITED STATES Current Status and Future Directions Summary of Scientific Sessions and Discussions September 13, 2010 Atlanta, Georgia Table of Contents Introduction . .4 . Agenda . 7 Summary Report Overview of Chronic Disease Prevention, Health Promotion and Reproductive Health . 9 Overview of Men’s Reproductive Health . 10 CDC’s Past and Current Men’s Reproductive Health Activities . 11 CDC’s Sexual Health Activity . 12 Comprehensive Reproductive Health Services for Men Visiting STD Clinics . 14 Overview of Male Contraception . 15 Overview of Male Infertility . 17 Fertility Preservation in the Male Patient with Cancer . 18 Modifiable Lifestyle Issues and Male Reproductive Health . 20 Mental Health Issues in Male Reproductive Health . 22 The Importance of Men’s Reproductive Health on Women’s Health and Fertility . 23 Involving Men in Reproductive Health and Family Planning Services . 24 Panel Perspectives on Men’s Reproductive Health . 25 Attachment 1 Registrants . 32 Attachment 2 References Cited by Presenters and Others . 41 Advancing Men’s Reproductive Health Summary of Scientific essions 3 Introduction This report contains a summary of presentations and discussions from the meeting, “Advancing Men’s Reproductive Health in the United States: Current Status and Future Directions .” The meeting was originally planned to help CDC staff and our Federal colleagues gain insights into the emerging areas of public health activities related to male reproductive health . What began as a “brown bag” seminar for CDC staff quickly developed into a one-day meeting of scientists, program managers, and clinicians . Through word-of-mouth, the Meeting Planning Committee received emails and calls from professionals asking to be included as attendees .
    [Show full text]
  • Fertility Outcome After Repeat Vasoepididymostomy
    0022-5347/99/1625-1626/0 THE JOURNAL OF UROLOGY Vol. 162, 1626–1628, November 1999 Copyright © 1999 by AMERICAN UROLOGICAL ASSOCIATION,INC. Printed in U.S.A. FERTILITY OUTCOME AFTER REPEAT VASOEPIDIDYMOSTOMY FABIO F. PASQUALOTTO, ASHOK AGARWAL, MEENA SRIVASTAVA, DAVID R. NELSON AND ANTHONY J. THOMAS, JR.* From the Center for Advanced Research in Human Reproduction and Infertility, and Departments of Urology, and Biostatistics and Epidemiology, Cleveland Clinic Foundation, Cleveland, Ohio ABSTRACT Purpose: Historically, epididymal obstruction has been treated with surgical reconstruction. We determine whether it is worthwhile for patients to undergo repeat surgical reconstruction after failed vasoepididymostomy or whether they should be advised only to undergo sperm acquisition for assisted reproductive technique. Materials and Methods: A total of 18 patients underwent repeat vasoepididymostomy per- formed by a single urologist (A. J. T.). Cases were divided based on the etiology of obstruction into groups 1—prior vasectomy (4), 2—congenital (7) and 3—inflammatory (7). Data were available regarding time of obstruction between initial and repeat vasoepididymostomy, quality of epidid- ymal fluid, levels of anastomoses, semen analyses at least 12 months after surgery for all 18 men and pregnancy rates based on more than 18 months of followup in 12. Results: Mean patient age at repeat vasoepididymostomy was 40.6 years (50.5, 36 and 39.4 years for groups 1, 2 and 3, respectively). Mean interval between vasectomy and initial vasoepi- didymostomy was 12.3 years (range 10 to 18). Mean interval between initial and repeat vaso- epididymostomy was 19 months (range 12 to 41). Of the patients 10 underwent unilateral and 8 bilateral anastomoses, for a total of 26 repeat anastomoses.
    [Show full text]
  • AUA 2019 Key Words
    AUA 2019 Key Words A Biochemical recurrence Biofeedback ACE Biologic predictors Acellular matrix Biomarkers Active surveillance Biopsy Acupuncture Bisphosphonates Adenocarcinoma Bladder Adenoma Bladder augmentation Adenovirus Bladder cancer Adrenal Bladder cells Adrenergic agonists Bladder contraction Adrenergic receptors Bladder dysfunction Adrenoceptor antagonists Bladder exstrophy Adverse events Bladder hyperactivity African Americans Bladder hypertrophy Age Bladder neck Algorithms Bladder neck obstruction Alpha-adrenergic blockade Bladder obstruction Alpha-blockers Bladder reconstruction Alpha-reductase inhibitor Bladder rupture Alpha-subtype selective compounds Bladder smooth muscle Ambiguous genitalia Bladder substitution Analgesia Bladder suspension Anatomy Bone Androgen Botulinum toxin Androgen antagonist BPH Andrology Brachytherapy Anesthesia Brain Angiogenesis Animal model C Antiangiogenesis Cadherin Antibiotics Calcium Antibody Calcium channel blocker Anticholinergics Calculi Antineoplastic agents Cancer Antioxidants Cardiovascular disease Antitumor effect Castration Apoptosis Catheterization Arteries and veins Artificial Cavernous nerve urinary sphincter Assisted Cell lines reproductive technology Cells Augmentation C-fiber Chemokines Autoimmune disease Chemotherapy Azoospermia Chromosomes Clinical protocols B Clinical trial Basic research Clusterin Behavioral modification Combination therapy Benign glands Complementary medicine Biochemical failure Complications Biochemical progression AUA 2019 Key Words Computer assisted
    [Show full text]
  • Robot-Assisted Vasovasostomy And
    Turk J Urol 2020; 46(5): 329-34 • DOI: 10.5152/tud.2020.20257 329 ENDOUROLOGY Invited Review Robot-assisted vasovasostomy and vasoepididymostomy: Current status and review of the literature Ali Serdar Gözen1,2 , Theodoros Tokas3 , Ahmed Tawfick1,4 , Waleed Mousa1,4 , Mohamed Kotb1,4 , Eirini Tzanaki5 , Jens Rassweiler1 Cite this article as: Gözen AS, Tokas T, Tawfick A, Mousa W, Kotb M, Tzanaki E, et al. Robot-assisted vasovasostomy and vasoepididymos- tomy: Current status and review of the literature. Turk J Urol 2020; 46(5): 329-34. ABSTRACT Objective: Microscope-assisted vasovasostomy (MAVV) is a standard procedure used to reverse vasecto- mies. Robotic surgery has been established primarily for technically demanding urological procedures and has also been recently implemented in male reproductive surgery. We aimed to review the current evidence of robot-assisted vasovasostomy (RAVV) and robot-assisted vasoepididymostomy (RAVE). Material and methods: We performed a systematic literature review using PubMed to identify relevant original articles. We identified 2017 records through database search, and after removing duplicates, 782 records remained for further analysis. Results: In total, 12 human and three animal studies were selected. Reported vasal patency rate ranges were ORCID iDs of the authors: 88%–100% for RAVVs and 55%–61% for RAVEs. The sperm count and postoperative pregnancy rates of 6 6 A.S.G. 0000-0002-9975-443X; RAVV ranged between 8.4 × 10 –120 × 10 sperm/mL and 65%, respectively. Finally, procedure times in the T.T. 0000-0003-0928-0507; human studies, recorded for extracorporeal RAVVs and RAVEs ranged from 97 to 238 minutes.
    [Show full text]